Cargando…

Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease

At the onset of the corona virus disease 19 (COVID-19) pandemic, there were concerns that patients with sickle cell disease (SCD) might be especially vulnerable to severe sequelae of SARS-CoV-2 infection. While two reports support this conclusion, multiple studies have reported unexpectedly favorabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madany, Emaan, Okwan-Duodu, Derick, Balbuena-Merle, Raisa, Hendrickson, Jeanne E., Gibb, David R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339405/ https://www.ncbi.nlm.nih.gov/pubmed/34368185 http://dx.doi.org/10.3389/fmed.2021.679030

Ejemplares similares

Altered type 1 interferon responses in alloimmunized and nonalloimmunized patients with sickle cell disease
por: Madany, Emaan, et al.
Publicado: (2021)

Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model
por: Lee, June Young, et al.
Publicado: (2020)

TMPRSS2 activity may mediate sex differences in COVID-19 severity
por: Okwan-Duodu, Derick, et al.
Publicado: (2021)

COVID-19 in cancer patients: risk, clinical features, and management
por: Liu, Cuiwei, et al.
Publicado: (2020)

RASAL3 Is a Putative RasGAP Modulating Inflammatory Response by Neutrophils
por: Saito, Suguru, et al.
Publicado: (2021)

Red Blood Cell Alloimmunization in Pediatric Sickle Cell Disease Population of Puerto Rico: An Observational Study
por: Balbuena-Merle, Raisa I., et al.
Publicado: (2020)

The carboxypeptidase angiotensin converting enzyme (ACE) shapes the MHC class I peptide repertoire
por: Shen, Xiao Z., et al.
Publicado: (2011)

Role of angiotensin-converting enzyme in myeloid cell immune responses
por: Cao, Duo-Yao, et al.
Publicado: (2020)

Red blood cell alloimmunization and sickle cell disease: a narrative review on antibody induction
por: Hendrickson, Jeanne E.
Publicado: (2020)

Myeloid expression of angiotensin converting enzyme facilitates myeloid maturation and inhibits the development of myeloid-derived suppressor cells
por: Shen, Xiao Z., et al.
Publicado: (2014)

Transfusion therapy for sickle cell disease: what’s new?
por: Chou, Stella T., et al.
Publicado: (2022)

One-Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement for Stenotic Bicuspid versus Tricuspid Aortic Valves: A Meta-Analysis and Meta-Regression
por: Quintana, Raymundo A., et al.
Publicado: (2019)

Type I interferon signature and cycling lymphocytes in macrophage activation syndrome
por: Huang, Zhengping, et al.
Publicado: (2023)

Impaired interferon signature in severe COVID-19
por: Gruber, Conor
Publicado: (2020)

The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease
por: Belcher, John D., et al.
Publicado: (2023)

Tumors exploit CXCR4(hi)CD62L(lo) aged neutrophils to facilitate metastatic spread
por: Peng, Zhenzi, et al.
Publicado: (2021)

A 2-Gene Signature Related to Interferon-Gamma Predicts Prognosis and Responsiveness to Immune Checkpoint Blockade of Glioma
por: Li, Yongzhe, et al.
Publicado: (2022)

Dysregulated early transcriptional signatures linked to mast cell and interferon responses are implicated in COVID-19 severity
por: MacCann, Rachel, et al.
Publicado: (2023)

COVID-19 and the Coombs test
por: Hendrickson, Jeanne E., et al.
Publicado: (2020)

Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
por: Ruetsch, Caroline, et al.
Publicado: (2021)

Subperiosteal Orbital Hematoma: A Rare Clinical Manifestation of Sickle Cell Disease - A Case Report
por: Hanna, Najib-Georges, et al.
Publicado: (2023)

Development of curative therapies for sickle cell disease
por: Tanhehco, Yvette C., et al.
Publicado: (2022)

Bullous hemorrhagic dermatosis is an under-recognized side effect of full dose low-molecular weight heparin: a case report and review of the literature
por: Russo, Armand, et al.
Publicado: (2018)

Inflammation and Interferon Signatures in Peripheral B-Lymphocytes and Sera of Individuals With Fibromyalgia
por: Fineschi, Serena, et al.
Publicado: (2022)

Specific Features of the Coagulopathy Signature in Severe COVID-19 Pneumonia
por: Blot, Mathieu, et al.
Publicado: (2021)

Severe Acute Chest Syndrome in a Sickle Cell Patient That Required Repeated Exchange Transfusion
por: Saleh, Mohammed, et al.
Publicado: (2021)

Glomerular filtration rate abnormalities in sickle cell disease
por: Afangbedji, Nowah, et al.
Publicado: (2022)

Chronic red cell exchange in sickle cell patients with iron overload may not affect mortality
por: Zhou, Yi Yuan, et al.
Publicado: (2022)

Telomere length correlates with disease severity and inflammation in sickle cell disease
por: Colella, Marina Pereira, et al.
Publicado: (2017)

The APC-EPCR-PAR1 axis in sickle cell disease
por: Ramadas, Nirupama, et al.
Publicado: (2023)

Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal
por: Thein, Swee Lay, et al.
Publicado: (2020)

Inflammation–Nature's Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing “the Epidemic” of Chronic Diseases
por: Bennett, Jeanette M., et al.
Publicado: (2018)

Microcytic Anemia: An Insidious Presentation of Sickle Cell Beta+ Thalassemia, a Rare Sickle Cell Variant
por: Shankar, Malavika, et al.
Publicado: (2022)

Interferon and autoantigens: intersection in autoimmunity
por: Antiochos, Brendan, et al.
Publicado: (2023)

Sickle cell disease chronic joint pain: Clinical assessment based on maladaptive central nervous system plasticity
por: Lopes, Tiago da Silva, et al.
Publicado: (2022)

Clonal hematopoiesis in sickle cell disease
por: Liggett, L. Alexander, et al.
Publicado: (2022)

Sickle Cell Disease: Thoughts for India From the Jamaican Cohort Study
por: Serjeant, Graham R.
Publicado: (2021)

Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease
por: Pavan, Aline Renata, et al.
Publicado: (2022)

Editorial: Developments in sickle cell disease therapy and potentials for gene therapy
por: Maitta, Robert W., et al.
Publicado: (2023)

Severe Subcutaneous Calcification in an Interferon-β-treated MS Patient
por: Masuda, Hiroki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d4a9kf6qhgai859fkk6tunf4mj